Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis
Aging Cell · 2025
DOI: 10.1111/acel.14336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Da-Long He und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Hea…. Hauptthemen laut MEDLINE: Tauopathies, Exocytosis, Glycogen Synthase Kinase 3. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The Science and Technology Program of Liaoning Province, The Liaoning Science and Technology Innovation Leading Talent Project.
Abstract (Originalsprache)
Glycogen synthase kinase‐3α/β (GSK3α/β) is a critical kinase for Tau hyperphosphorylation which contributes to neurodegeneration. Despite the termination of clinical trials for GSK3α/β inhibitors in Alzheimer's disease (AD) treatment, there is a pressing need for novel therapeutic strategies targeting GSK3α/β. Here, we identified the compound AS1842856 (AS), a specific forkhead box protein O1 (FOXO1) inhibitor, reduced intracellular GSK3α/β content in a FOXO1‐independent manner. Specifically, AS directly bound to GSK3α/β, promoting its translocation to the multivesicular bodies (MVBs) and accelerating exocytosis, ultimately decreasing intracellular GSK3α/β content. Expectedly, AS treatment effectively suppressed Tau hyperphosphorylation in cells exposed to okadaic acid or expressing the Tau P301S mutant. Furthermore, AS was visualized to penetrate the blood–brain barrier (BBB) using an imaging mass microscope. Long‐term treatment of AS enhanced cognitive function in P301S transgenic mice by mitigating Tau hyperphosphorylation through downregulation of GSK3α/β expression in the brain. Altogether, AS represents a novel small‐molecule GSK3α/β inhibitor that facilitates GSK3α/β exocytosis, holding promise as a therapeutic agent for GSK3α/β hyperactivation‐associated disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Health Sciences Institute of China Medical University, Shenyang, China.
- CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.
- First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
- Department of Radiology, The First Hospital of China Medical University, Shenyang, China.
ORCID-Profile: Zhan-You Wang
Förderung
- The National Natural Science Foundation of China
- The Science and Technology Program of Liaoning Province
- The Liaoning Science and Technology Innovation Leading Talent Project
- National Natural Science Foundation of China
Zitieren
APA
He, D. L., Zhang, X. Y., Su, J. Y., Zhang, Q., Zhao, L. X., Wu, T. Y., Ren, H., Jia, R. J., Lei, X. F., Hou, W. J., Sun, W. G., Fan, Y. G., & Wang, Z. Y. (2025). Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis. Aging Cell. https://doi.org/10.1111/acel.14336
Vancouver
He DL, Zhang XY, Su JY, Zhang Q, Zhao LX, Wu TY, et al. Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis. Aging Cell. 2025. doi:10.1111/acel.14336
BibTeX
@article{He2025,
author = {He, Da-Long and Zhang, Xiao-Yu and Su, Jing-Yang and Zhang, Qi and Zhao, Ling-Xiao and Wu, Ting-Yao and Ren, Hang and Jia, Rong-Jun and Lei, Xian-Fang and Hou, Wen-Jia and Sun, Wen-Ge and Fan, Yong-Gang and Wang, Zhan-You},
title = {Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.14336}
}
EUVIMED